Compounds > pazufloxacin
Page last updated: 2024-08-24

pazufloxacin and imipenem, anhydrous

pazufloxacin has been researched along with imipenem, anhydrous in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukuda, H; Kawamura, Y1
Fukuda, T; Furuta, Y; Minami, S; Mitsuyama, J; Nakata, M; Nomura, N; Takahata, M; Yamada, H1
Doi, M; Fujiue, Y; Kuwabara, M; Muroki, K; Shimizu, S; Watanabe, Y; Yano, S1
Akata, K; Fukuda, K; Ishimoto, H; Kato, K; Kawanami, T; Mukae, H; Naito, K; Noguchi, S; Taniguchi, H; Yamasaki, K; Yatera, K1

Other Studies

4 other study(ies) available for pazufloxacin and imipenem, anhydrous

ArticleYear
[Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration].
    The Japanese journal of antibiotics, 2002, Volume: 55, Issue:3

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; beta-Alanine; Biphenyl Compounds; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Convulsants; Drug Combinations; Drug Interactions; Enoxacin; Fleroxacin; Fluoroquinolones; Imipenem; Injections, Intravenous; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Norfloxacin; Oxazines; Penicillin G; Quinolones; Seizures; Thienamycins

2002
[In vitro and in vivo antibacterial activities of pazufloxacin mesilate, a new injectable quinolone].
    The Japanese journal of antibiotics, 2002, Volume: 55, Issue:4

    Topics: 4-Quinolones; Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; beta-Alanine; Ceftazidime; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; DNA Topoisomerase IV; Dose-Response Relationship, Drug; Drug Combinations; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infusions, Intravenous; Male; Meropenem; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Oxazines; Rats; Thienamycins; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors

2002
[Antimicrobial susceptibility of Pseudomonas aeruginosa isolated from urine at one hospital to mainly carbapenem and fluoroquinolone drugs].
    The Japanese journal of antibiotics, 2006, Volume: 59, Issue:2

    Topics: Amikacin; Anti-Infective Agents; Carbapenems; Ceftazidime; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Imipenem; Meropenem; Oxazines; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Urine

2006
Successful Additional Corticosteroid Treatment in a Patient with Mycoplasma pneumoniae Pneumonia in whom a Monobacterial Infection was Confirmed by a Molecular Method Using Bronchoalveolar Lavage Fluid.
    Internal medicine (Tokyo, Japan), 2016, Volume: 55, Issue:6

    Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Cilastatin; Cilastatin, Imipenem Drug Combination; Clindamycin; Disease Progression; Drug Combinations; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Imipenem; Minocycline; Mycoplasma pneumoniae; Oxazines; Pneumonia, Mycoplasma; Radiography, Thoracic; RNA, Ribosomal, 16S; Treatment Outcome

2016